Clinical Trial Detail

NCT ID NCT01999972
Title A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

clear cell renal cell carcinoma

Advanced Solid Tumor

Therapies

Axitinib + Crizotinib

Age Groups: adult senior

No variant requirements are available.